← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2006Last known activity
Sep 30, 2025
Timeline
1900s
- Jan 1, 1907
St. Justine's Hospital— Founded
Drugs by trial phase (31 distinct, 30 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Anemia, Sickle Cell
- Asthma
- Bronchiolitis
- Cholestasis
- Chromosome Aberrations
- Chromosome Disorders
- Conjunctivitis
- Conjunctivitis, Allergic
- Crohn Disease
- Fragile X Syndrome
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Glioma
- Hypersensitivity
- Intellectual Disability
- Lacerations
- Lichen Sclerosus et Atrophicus
- Neurobehavioral Manifestations
- Neurofibroma
- Neurofibroma, Plexiform
- Neurofibromatoses
- Sex Chromosome Disorders
- Syndrome
- Vulvar Lichen Sclerosus
- Whooping Cough
- X-Linked Intellectual Disability
Recent trials (50)
- NCT06785272CollaboratorPhase 3Sep 30, 2025
- NCT06906068Sponsor investigatorN/AJun 2, 2025
- NCT06906068OfficialN/AJun 2, 2025
- NCT06906068Lead sponsorN/AJun 2, 2025
- NCT06666348Lead sponsorPhase 1/Phase 2Jan 1, 2025
- NCT06666348Sponsor investigatorPhase 1/Phase 2Jan 1, 2025
- NCT06081348CollaboratorPhase 2Oct 31, 2023
- NCT05915806Overall official - principal investigatorN/AJul 30, 2023
- NCT05653024Sponsor investigatorPhase 3Feb 15, 2023
- NCT05653024Lead sponsorPhase 3Feb 15, 2023
- NCT05378776Lead sponsorN/AMay 11, 2022
- NCT05378776Sponsor investigatorN/AMay 11, 2022
- NCT05099055Lead sponsorPhase 3Jan 31, 2022
- NCT05099055Reponsible party - principal investigatorPhase 3Jan 31, 2022
- NCT04872218Sponsor investigatorPhase 2Nov 1, 2021
Details
- Founded
- Montreal, CA Jan 1, 1907
- Last known activity
- Sep 30, 2025